That’s it for 2025’s Q1 clinical trials round-up. If you have a study that could fit the bill for our next column, please ...

The progress made in liver disease research to date presents an opportunity for further advancements in the near future.

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, ...

Improving Global Access to Life-Changing Therapeutics... Following the successful Boston and London meetings, the ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

President Donald Trump has signed an executive order that he claims will cut prescription drug prices supplied to the US to ...

"We can use…AI to estimate a person's biological age from face pictures, and our study shows that information can be ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...